ATTR-PN
Showing 1 - 25 of 330
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy,
Recruiting
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- +2 more
- NTLA-2001
-
Paris, France
- +3 more
Nov 29, 2022
Transthyretin Amyloid Polyneuropathy (ATTR-PN) Trial in China (tafamidis meglumine)
Active, not recruiting
- Transthyretin Amyloid Polyneuropathy (ATTR-PN)
- tafamidis meglumine
-
Beijing, Beijing, China
- +7 more
Nov 21, 2022
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy Trial (Acoramidis)
Withdrawn
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- (no location specified)
Jan 26, 2022
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy Trial in San Francisco (AG10, Placebo)
Withdrawn
- Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
- AG10
- Placebo
-
San Francisco, CaliforniaEidos Therapeutics
Jun 11, 2021
Prospective Evaluation of NfL as a Biomarker in ATTRv
Not yet recruiting
- Amyloidosis, Hereditary
- (no location specified)
May 18, 2023
Aortic Stenosis and Cardiac Amyloidosis
Recruiting
- Cardiac Amyloidosis
- Aortic Stenosis
- Amyloid-specific treatment
- No amyloid-specific treatment
-
Vienna, Austria
- +1 more
Nov 8, 2023
Lumbar Spine Stenosis Specimens for Identification of
Not yet recruiting
- Lumbar Spinal Stenosis
- +5 more
- Tc99-PYP or Tc99-HDMP Scan
-
Beverly Hills, California
- +5 more
Sep 12, 2023
Mitral Regurgitation, ATTR-Cardiomyopathy, Edge-to-Edge Mitral Valve Repair Trial (TEER, Optimal Medical Therapy)
Not yet recruiting
- Mitral Regurgitation
- +2 more
- TEER
- Optimal Medical Therapy
- (no location specified)
Oct 4, 2023
Transthyretin Amyloidosis Trial in Beijin (Tafamidis Pill)
Recruiting
- Transthyretin Amyloidosis
- Tafamidis Pill
-
Beijin, ChinaPeking University Third Hospital
Jul 7, 2021
Transthyretin Amyloidosis in Left Ventricular Hypertrophy of
Completed
- Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)
- Diagnosis of TTR amyloidosis cardiomyopathy
-
Chermside, Australia
- +17 more
Nov 3, 2022
Cardiomyopathies, Primary Trial ((18F)Flutemetamol)
Recruiting
- Cardiomyopathies, Primary
-
New Haven, ConnecticutYale University
Oct 11, 2022
Transthyretin Amyloidosis Outcome Survey (THAOS)
Recruiting
- Transthyretin Gene Mutations
- Transthyretin Amyloidosis
- None. Observational Study.
-
Birmingham, Alabama
- +110 more
Feb 1, 2022
ATTR Cardiac Amyloidosis in Patients Undergoing TAVR
Not yet recruiting
- ATTR Amyloidosis Wild Type
- +3 more
- (no location specified)
Aug 23, 2023
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy Trial (NTLA-2001, Placebo)
Not yet recruiting
- Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
- NTLA-2001
- Placebo
- (no location specified)
Nov 8, 2023
Quantitative-imaging in Cardiac Transthyretin Amyloidosis
Recruiting
- ATTR-CM
- 18F-fluoride PET
-
Groningen, NetherlandsUniversity Medical Centre Groningen
Mar 16, 2023
Transthyretin Amyloidosis Trial in New York (I 124-Evuzamitide)
Recruiting
- Transthyretin Amyloidosis
- I 124-Evuzamitide
-
New York, New YorkColumbia University Irving Medical Center
Nov 23, 2022
CGM-Assisted Management of PN
Not yet recruiting
- Intestinal Failure
- +2 more
-
Boston, MassachusettsBoston Children's Hospital
Jun 5, 2023
Transthyretin Cardiac Amyloidosis Trial in Dallas (Tafamidis 61 MG)
Not yet recruiting
- Transthyretin Cardiac Amyloidosis
- Tafamidis 61 MG
-
Dallas, TexasUT Southwestern Medical Center
Aug 2, 2022
Prurigo Nodularis Trial (Dupilumab SAR231893 (REGN668))
Not yet recruiting
- Prurigo Nodularis
- Dupilumab SAR231893 (REGN668)
- (no location specified)
Oct 11, 2023
Clinical Decision Support System Trial in Athens (CDSS Canceling)
Completed
- Clinical Decision Support System
- CDSS Canceling
-
Athens, GreeceIaso General Hospital
Dec 30, 2022
Occult Cardiac Amyloidosis
Recruiting
- Detection of Occult Cardiac Amyloidosis
-
Essen, NRW, GermanyUniversity Hospital Essen
Jan 11, 2023
Transthyretin Amyloidosis Trial in New Haven (Computer algorithm for ATTR)
Not yet recruiting
- Transthyretin Amyloidosis
- Computer algorithm for ATTR
-
New Haven, ConnecticutYale New Haven Hospital
Jan 20, 2023
Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) Trial in Indianapolis (Eplontersen)
Recruiting
- Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
-
Indianapolis, IndianaIndiana University Health University Hospital
Jan 12, 2023